What You Need to Know
Both cases involved men older than 50 years with chronic conditions and occupational dromedary camel exposure, and one also drank raw camel milk.
One patient tested negative on an upper respiratory PCR specimen, and infection was confirmed only through lower respiratory sampling.
CDC reports no specific antiviral or vaccine for MERS, a case fatality rate of 30% to 40%, and a very low current risk to the US public
MERS: Transmission, Symptoms, and Treatment
The Centers for Disease Control and Prevention (CDC) describes MERS as a viral respiratory illness caused by MERS-CoV, with most cases detected in or near the Arabian Peninsula.² The virus spreads from dromedary camels to people through close contact, and limited person-to-person spread can occur in households, during travel, and in health care facilities. The largest outbreak outside the Arabian Peninsula occurred in the Republic of Korea in 2015.²
Symptoms typically appear five or six days after exposure, with a range of two to 14 days.² Fever, cough, and shortness of breath predominate, and some patients report diarrhea, nausea, or vomiting. Most reported cases developed pneumonia, and kidney failure has also occurred.²
CDC estimates 30% to 40% of reported patients with MERS have died, most with at least one preexisting medical condition.² Older age, chronic heart, kidney, or lung disease, diabetes, and certain cancers raise the risk of severe complications. No specific antiviral treatment is recommended, no vaccine is available, and management remains supportive.²
Only 2 patients in the United States have ever tested positive for MERS-CoV, both travel-associated cases in May 2014 involving health care providers who had worked in Saudi Arabia.² CDC considers the current risk to the general US public very low and does not recommend changing travel plans. The agency advises patients with fever or respiratory symptoms to report recent travel to the Arabian Peninsula, camel contact, or exposure to a person with MERS.²
Contagion has also tracked the broader merbecovirus threat. In February 2025, and reported on HKU5-CoV-2, a bat merbecovirus related to MERS-CoV, which investigators found can use human ACE2 for cell entry and infect human respiratory and enteric organoids.⁴ The study authors warned of a high spillover risk, though further research is needed to define it.⁴
WHO continues to call for coordinated One Health investigations, enhanced camel surveillance, and prompt data sharing among affected countries.¹ The agency also advises people with chronic conditions or weakened immune systems to avoid close contact with camels and camel products.¹
References
World Health Organization. Middle East respiratory syndrome (MERS), Qatar. Disease Outbreak News. November 13, 2026. Accessed November 17, 2026. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON626
Centers for Disease Control and Prevention. About Middle East respiratory syndrome (MERS). Accessed November 17, 2026. https://www.cdc.gov/coronavirus/mers/